Global Heart Failure Academy

Leading global experts have combined guideline recommendations and new clinical data with practical, case-based formats that approximate clinical reality to improve patient outcomes in the management of heart failure. This series is focused on changing clinical behavior in the recognition and diagnoses of hyperkalemia and iron deficiency in heart failure, through the application of emerging science into everyday practice.
To return to the Global Heart Failure Academy, please click here.
This educational series is developed by Medtelligence. Supported by an unrestricted educational grant from Vifor Pharma.

Episodes 1-16 of 21

- Mikhail Kosiborod, MD
  Peer
- Michael Böhm, MD, FESC
  Peer
7
Global Heart Failure Academy
The 4 Pillars of Treatment in HFrEF: Does Risk of Hyperkalemia Threaten to Topple Them Over?
The 4 Pillars of Treatment in HFrEF: Does Risk of Hyperkalemia Threaten to Topple Them Over?
The 4 Pillars of Treatment in HFrEF: Does Risk of Hyperkalemia Threaten to Topp…
- Marco Metra, MD
  Peer
- Adrian F. Hernandez, MD, MHS
  Peer
6
Global Heart Failure Academy
From Paper to Patient: Applying Guideline Updates to Practice
From Paper to Patient: Applying Guideline Updates to Practice
From Paper to Patient: Applying Guideline Updates to Practice
- Mikhail Kosiborod, MD
  Peer
- Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
  Peer
12
CME/CE
New Perspectives in Managing HF and HK – The Cardiorenal Angle
New Perspectives in Managing HF and HK – The Cardiorenal Angle
0.25 credits
New Perspectives in Managing HF and HK – The Cardiorenal Angle
0.25 credits
- Josep Comin-Colet, MD, PhD
  Peer
10
CME/CE
Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure
Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure
0.25 credits
Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Stefan D. Anker, MD, PhD
  Peer
17
CME/CE
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results
0.25 credits
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Toplin…
0.25 credits
- Peter van der Meer, MD, PhD
  Peer
- Pieter Martens, MD, PhD
  Peer
8
CME/CE
New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remodeling
New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remodeling
0.25 credits
New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remode…
0.25 credits
- George L. Bakris, MD
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
3
CME/CE
Optimizing RAASi Therapy: The Role of Personalized Medicine
Optimizing RAASi Therapy: The Role of Personalized Medicine
0.25 credits
Optimizing RAASi Therapy: The Role of Personalized Medicine
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Piotr Ponikowski, MD, PHD, FESC, FHFA
  Peer
8
Global Heart Failure Academy
Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart Failure
Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart Failure
Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart…
- Gregg C. Fonarow, MD
  Peer
- Andrew J. S. Coats, MD
  Peer
5
CME/CE
Applying Key Updates from ESC/HFA to Managing Heart Failure
Applying Key Updates from ESC/HFA to Managing Heart Failure
0.25 credits
Applying Key Updates from ESC/HFA to Managing Heart Failure
0.25 credits
- Keith C. Ferdinand, MD
  Peer
- Marco Metra, MD
  Peer
9
CME/CE
Managing HK in HF: Navigating the Evolving Clinical Landscape
Managing HK in HF: Navigating the Evolving Clinical Landscape
0.25 credits
Managing HK in HF: Navigating the Evolving Clinical Landscape
0.25 credits
- Mikhail Kosiborod, MD
  Peer
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
- Phil McEwan, PhD
  Peer
5
CME/CE
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
0.25 credits
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeco…
0.25 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
5
CME/CE
From Guidelines to Practice: Key Updates From 2021 HFSA
From Guidelines to Practice: Key Updates From 2021 HFSA
0.25 credits
From Guidelines to Practice: Key Updates From 2021 HFSA
0.25 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Gregg C. Fonarow, MD
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
6
CME/CE
Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities to Improve Patient Outcomes
Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities to Improve Patient Outcomes
1.50 credits
Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities t…
1.50 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
- Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
  Peer
8
CME/CE
A New Normal? COVID-19 and HF in Clinical Trials
A New Normal? COVID-19 and HF in Clinical Trials
0.25 credits
A New Normal? COVID-19 and HF in Clinical Trials
0.25 credits
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
  Peer
- Peter van der Meer, MD, PhD
  Peer
8
CME/CE
A Clinical Guide to the Role of Iron in HF Pathophysiology
A Clinical Guide to the Role of Iron in HF Pathophysiology
0.25 credits
A Clinical Guide to the Role of Iron in HF Pathophysiology
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
4
CME/CE
Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders
Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders
0.25 credits
Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium B…
0.25 credits